Search

Displaying results 7611 - 7620 of 8696 in total
  1. Drug

    Libivirumab

    go.drugbank.com/drugs/DB17748
    Experimental

    Libivirumab is an investigational monoclonal antibody.

  2. Target

    L-selectin

    go.drugbank.com/bio_entities/BE0010361
    TargetHumans

    Calcium-dependent lectin that mediates cell adhesion by binding to glycoproteins on neighboring cells (PubMed:12403782, PubMed:28011641, PubMed:28489325). Mediates the adherence of lymphocytes to endothelial cells of high endothelial ven...

    Synonyms: Lymph node homing receptor
  3. Drug

    Esuprone

    go.drugbank.com/drugs/DB20862
    Experimental

    Esuprone is a small molecule drug. Esuprone has a monoisotopic molecular weight of 282.06 Da.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  4. Drug

    Cilansetron

    go.drugbank.com/drugs/DB04885
    Experimental

    Cilansetron is a 5HT-3 antagonist made by Solvay Pharmaceuticals that is currently under trial phase in the EU and US.

    Categories: Drugs for Functional Gastrointestinal Disorders, Serotonin Receptor Antagonists
  5. Drug

    Suxibuzone

    go.drugbank.com/drugs/DB13232
    Experimental

    Categories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical Use
  6. Drug

    R-348

    go.drugbank.com/drugs/DB06321
    Investigational

  7. Drug

    Inodiftagene vixteplasmid

    go.drugbank.com/drugs/DB16017
    Investigational

    Inodiftagene vixteplasmid is a plasmid DNA vector encoding the diphtheria toxin A (dT-a) gene under transcriptional regulation of the promoter region of the human H19 gene (an imprinted maternally expressed

  8. Drug

    Lofentanil

    go.drugbank.com/drugs/DB09174
    ExperimentalIllicit

    Lofentanil is an analog of fentanyl and is one of the most potent opioids available today.

  9. Drug

    Torcetrapib

    go.drugbank.com/drugs/DB06281
    Investigational

    Torcetrapib (CP-529414, Pfizer) was developed to treat hypercholesterolemia but its development was halted in 2006 when phase III studies showed excessive mortality in the treatment group receiving a combination of atorvastatin and the s...

  10. Drug

    Talacotuzumab

    go.drugbank.com/drugs/DB14796
    Investigational

    Talacotuzumab is an IgG1 monoclonal antibody directed toward the IL3 receptor α–subunit, also known as CD123.